Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Foley partners Nate Beaver, co-chair of the firms Medical Devices Area of Focus, and David Rosen, leader of the firms FDA Practice Group, will discuss what the future has in store for compounded GLP-1 drugs
These medications help people feel fuller for longer, reduce hunger, and slow down digestion
You do not need to be a Florida resident
Forging a path to fiscally sustainable coverage of AOM Should you choose to cover GLP-1 AOMs, what are ways to ensure appropriate utilization, optimize outcomes, and drive towards some degree of quantifiable positive cost and benefit and added value
US$ 25.61
US$ 22.36
US$ 28.95
